Harvard Bioscience Inc. (HBIO)

NASDAQ: HBIO · Real-Time Price · USD

0.34

-0.02 (-4.57%)

At close: May 01, 2025, 3:59 PM

0.36

3.51%

Pre-market: May 02, 2025, 08:53 AM EDT

Harvard Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	4.11M	4.28M	4.51M	7.82M	8.32M	8.34M	8.17M	5.73M	5.6M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	-333K	-1.56M	-255K	-251K	-211K	n/a	n/a
Other Long-Term Assets	2.83M	6.47M	13.6M	12.27M	8.85M	10.74M	4.92M	324K	128K
Receivables	14.87M	16.1M	16.7M	21.83M	17.77M	20.7M	21.46M	13.38M	15.75M
Inventory	23.25M	24.72M	26.44M	27.59M	22.26M	22.06M	25.09M	21.35M	19.95M
Other Current Assets	2.9M	3.94M	3.47M	4.34M	3.35M	2.47M	3.11M	12.11M	n/a
Total Current Assets	45.12M	49.04M	51.12M	61.58M	51.7M	53.57M	54.72M	47.53M	45.47M
Property-Plant & Equipment	11.24M	8.75M	3.37M	3.42M	3.96M	4.78M	5.9M	4.14M	4.3M
Goodwill & Intangibles	67.46M	73.1M	77.27M	85.07M	91.74M	95.79M	102.53M	57.17M	56.71M
Total Long-Term Assets	81.53M	88.33M	94.24M	100.76M	104.55M	111.3M	113.35M	61.82M	62.29M
Total Assets	126.64M	137.37M	145.36M	162.34M	156.25M	164.87M	168.07M	109.35M	107.77M
Account Payables	4.79M	5.55M	6.45M	4.91M	5.97M	5.34M	7.36M	4.41M	6.2M
Deferred Revenue	3.81M	n/a	3.37M	4.27M	3.77M	3.95M	4.19M	633K	500K
Short-Term Debt	36.96M	5.86M	3.81M	3.23M	1.72M	6.9M	2M	2.77M	2.37M
Other Current Liabilities	8.25M	13.71M	7.49M	4.71M	3.48M	3.54M	4.45M	3.61M	3.84M
Total Current Liabilities	54.96M	26.54M	23.25M	25.32M	21.05M	25.31M	21.51M	14.04M	14.6M
Long-Term Debt	n/a	30.7M	43.01M	45.09M	46.29M	46.92M	58.8M	8.98M	11.37M
Other Long-Term Liabilities	7.64M	1.48M	1.01M	486K	2.85M	749K	3.29M	5.43M	3.18M
Total Long-Term Liabilities	8.35M	37.75M	49.89M	53.63M	58.52M	57.86M	64.38M	14.41M	20.97M
Total Liabilities	63.3M	64.29M	73.14M	78.94M	79.57M	83.18M	85.89M	28.45M	35.57M
Total Debt	44.49M	42.77M	46.82M	48.33M	48.01M	53.82M	60.8M	11.75M	13.75M
Common Stock	n/a	434K	454K	452K	444K	438K	436K	419K	418K
Retained Earnings	-158.01M	-145.6M	-142.19M	-132.67M	-132.39M	-124.58M	-119.89M	-116.97M	-116.03M
Comprehensive Income	-15.67M	-14.19M	-15.05M	-10.03M	-13.07M	-12.69M	-13.53M	-10.68M	-16.66M
Shareholders Equity	63.34M	73.07M	72.22M	83.4M	76.68M	81.69M	82.18M	80.9M	72.2M
Total Investments	n/a	n/a	-333K	-1.56M	-255K	-251K	-211K	n/a	n/a